Jinming Xing, PharmD

As a Diagnostics Operations Lead within Pfizer’s Diagnostics group, Jinming provides operational oversight to CDx programs and work towards advancing CDx development and delivery. Previously as part of the Biomarker Development group at Novartis, Jinming spearheaded the design and conduct of pilot studies evaluating microsampling technologies. He had also conducted bioanalytical work on LC-MS/MS to support DMPK studies and had earned his PharmD at The Ohio State University.

“Becoming a father gave me brand new perspectives to the work that I do”